Xuejun Liu
Qingdao University(CN)Affiliated Hospital of Qingdao University(CN)
Publications by Year
Research Areas
Atrial Fibrillation Management and Outcomes, Diabetes Treatment and Management, Venous Thromboembolism Diagnosis and Management, Urban Transport and Accessibility, Heart Failure Treatment and Management
Most-Cited Works
- → Pharmacokinetics and pharmacodynamics of dapagliflozin, a novel selective inhibitor of sodium–glucose co‐transporter type 2, in Japanese subjects without and with type 2 diabetes mellitus(2011)113 cited
- → Lack of pharmacokinetic interaction between dapagliflozin, a novel sodium–glucose transporter 2 inhibitor, and metformin, pioglitazone, glimepiride or sitagliptin in healthy subjects(2010)87 cited
- → Effects of rifampin and mefenamic acid on the pharmacokinetics and pharmacodynamics of dapagliflozin(2012)65 cited
- → The Effects of Implementing a Mobile Health–Technology Supported Pathway on Atrial Fibrillation–Related Adverse Events Among Patients With Multimorbidity(2021)59 cited
- → Effect of a high‐fat meal on the pharmacokinetics of dapagliflozin, a selective SGLT2 inhibitor, in healthy subjects(2011)48 cited
- → Measuring the effects of job competition and matching on employment accessibility(2020)27 cited